Dalian Merro Pharmaceutical Co. Ltd   Report issue

For profit Phase 2
Founded: Dalian China (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2013
NCT01762514
First Marketed Drug
2000
ibuprofen (motrin)
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

MERRO PHARM | MERRO PHARM USA

Active Ingredients

Marketed Drugs (3)

ibuprofen (motrin) (1987)

phentermine (wyamine) (2016)

tramadol (Ultram) (2019)

Drugs in Phase 2 Trials (1)

amifostine (ethyol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Marrow Diseases (Phase 2)

Mucositis (Phase 2)

Nasopharyngeal Neoplasms (Phase 2)

Salivary Gland Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1